Osteoimmunopathology
Francesco Chiappelli 2011 Evidence-Based Perspectives from Molecular Biology to Systems Biology The U.S. Patient Protection and Affordable Care Act (enacted on 23 March 2010) created a $1 billion program to award, on a competitive basis, federal subsidies to qualifying therapeutic discovery projects being conducted at small biomedical companies.
Continue reading →